ROIVANT SOCIAL VENTURES INC: Form 990, tax year 2024
View the entire original 990 at ProPublica ↗
- Organization
- ROIVANT SOCIAL VENTURES INC (EIN 83-3947490)
- Tax period
- 2024-04-01 to 2025-03-31
- Filed
- 2026-02-16
- IRS object ID
- 202630479349301393
- Schema version
- 2024v5.5
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule I
- Schedule J
- Schedule L
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2026-02-16T16:38:31-06:00 | ReturnTs |
| Tax Period End | 2025-03-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 871353108 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | EISNER ADVISORY GROUP LLC | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 733 THIRD AVENUE | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 100172703 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2024-04-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 833947490 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ROIVANT SOCIAL VENTURES INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | ROIV | BusinessNameControlTxt |
| Phone | 2128476204 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1 PENNSYLVANIA PLAZA 54TH FL | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10119 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | LINDSAY ANDROSKI | PersonNm |
| Person Title | PRESIDENT AND CEO | PersonTitleTxt |
| Phone | 9146349551 | PhoneNum |
| Signature | 2026-02-16 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | Yes (1) | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | GINA RACHEL | PreparerPersonNm |
| PTIN | P01216293 | PTIN |
| Phone | 2129498700 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2024 | TaxYr |
| Build TS | 2025-03-06 01:10:19Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Change | Yes (X) | AddressChangeInd |
| Principal Officer | LINDSAY ANDROSKI | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1 PENNSYLVANIA PLAZA 54TH FL | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10119 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $306,829 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.ROIVANTSV.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2018 | FormationYr |
| Legal Domicile State | DE | LegalDomicileStateCd |
| Activity Or Mission | PROMOTE SYSTEMIC, SUSTAINED IMPROVEMENTS TO THE WAY HEALTHCARE IS ACCESSED AND DELIVERED. | ActivityOrMissionDesc |
| Voting Members Governing Body | 5 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 0 | VotingMembersIndependentCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Total Volunteers | 47 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $110,143 | PYContributionsGrantsAmt |
| CY Contributions Grants | $305,032 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $13,750 | PYInvestmentIncomeAmt |
| CY Investment Income | $1,797 | CYInvestmentIncomeAmt |
| PY Other Revenue | $0 | PYOtherRevenueAmt |
| CY Other Revenue | $0 | CYOtherRevenueAmt |
| PY Total Revenue | $123,893 | PYTotalRevenueAmt |
| CY Total Revenue | $306,829 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $0 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $23,481 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $0 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $0 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $24,010 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $254,637 | PYOtherExpensesAmt |
| CY Other Expenses | $263,754 | CYOtherExpensesAmt |
| PY Total Expenses | $254,637 | PYTotalExpensesAmt |
| CY Total Expenses | $287,235 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$130,744 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $19,594 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $627,351 | TotalAssetsBOYAmt |
| Total Assets EOY | $408,573 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $258,804 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $24,000 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $368,547 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $384,573 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | SEE SCHEDULE OOUR MISSION IS TO IMPROVE EQUITY IN HEALTH CARE ACCESS AND OUTCOMES ACROSS GEOGRAPHIES, SOCIOECONOMICS, AND DEMOGRAPHICS ON A NOT-FOR-PROFIT, CHARITABLE BASIS. WE USE INNOVATIONS IN SCIENCE AND TECHNOLOGY TO CHALLENGE AND ADVANCE THE NORMS OF BIOPHARMA AND HEALTH CARE DELIVERY. OUR WORK IS ACROSS TWO STRATEGIES: (I) INVESTMENTS AND INCUBATION LEADERSHIP TO EARLY-STAGE INNOVATIVE HEALTH ACCESS, MANUFACTURING, AND DRUG DEVELOPMENT ORGANIZATIONS WITH NO OR LOW-COST "PATIENT" CAPITAL AND RESOURCES; (II) CHARITABLE PARTNERSHIPS AND EDUCATIONAL INITIATIVES ACROSS INDUSTRY, PATIENT ADVOCACY, AND INVESTORS ACCELERATING DEVELOPMENT OF NEW MEDICINES. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $163,370 | ExpenseAmt |
| Grant | $23,481 | GrantAmt |
| Desc | SEE SCHEDULE OTHE ORGANIZATION HAD THE FOLLOWING INITIATIVES FOR THE FISCAL-YEARENDING MARCH 31, 2025:(I) TEACHING ROIVANT SOCIAL VENTURES' "MAKING MEDICINES" COURSE AT THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL'S ESHELMAN SCHOOL OF PHARMACY, THE NUMBER ONE RANKED PHARMACY SCHOOL IN THE UNITED STATES. WE DESIGNED AND LAUNCHED THIS INNOVATIVE COURSE IN 2023 TO INTRODUCE PHARMD STUDENTS TO THE NEW DRUG APPROVAL PROCESS AND KEY ISSUES IN DRUG DISCOVERY, PRE-CLINICAL TESTING, CLINICAL TRIALS, FDA APPROVAL, AND GLOBAL ACCESS TO MEDICINES. THE COURSE IS IN HIGH DEMAND AND RECEIVED MULTIPLE TEACHING AWARDS. (II) GROWING ROIVANT SOCIAL VENTURES' INAUGURAL ACCESS TO MEDICINES PHARMA INTERNSHIPS AND ACCESS TO MEDICINES GLOBAL FELLOWSHIPS FOR TALENTED PHARMD STUDENTS FROM GROUPS WITH DISPROPORTIONATE UNMET NEEDS IN MEDICINE. IN 2023 THE PROGRAM PROVIDED REAL-WORLD DRUG DEVELOPMENT EXPERIENCE TO FOUR HIGHLY QUALIFIED PHARMD STUDENTS. IN 2024 WE EXPANDED THE PROGRAM TO FIVE STUDENTS. (III) CONTINUING OUR THOUGHT LEADERSHIP CAMPAIGN THROUGH HOSTING EVENTS LIKE "INCREASING IMPACT: LEVERAGING DATA TO DRIVE HEALTHCARE ACCESS AND ADVANCEMENT," THAT PROVIDED INCREASED VISIBILITY AND EDUCATION ON ISSUES IN HEALTHCARE ACCESS, AND SPEAKING AT EVENTS WITH ORGANIZATIONS LIKE THE TERMEER FOUNDATION, BIO'S CEO AND INVESTOR CONFERENCE, THE ADVANCING WOMEN'S LEADERSHIP IN PHARMA AND HEALTHCARE CONFERENCE, THE NATIONAL VACCINE LAW CONFERENCE, AND 50/50 WOMEN ON BOARDS. (IV) LAUNCHED OUR INAUGURAL CONVERGENCE FORUM FELLOWSHIPS, WHICH PROVIDED SUPPORT FOR HIGHLY TALENTED FIRST-TIME FEMALE AND UNDERREPRESENTED CEOS TO ATTEND AN INTIMATE, INVITATION ONLY CONFERENCE OF PROMINENT HEALTHCARE LEADERS.(V) LAUNCHING OUR HEALTH EQUITY SPOTLIGHT SERIES, WHICH HIGHLIGHTS ORGANIZATIONS INCREASING ACCESS TO RESEARCH, MEDICINE, AND MEDICAL CARE FOR UNDERSERVED PATIENT GROUPS. | Desc |
| Total Program Service Expenses | $163,370 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | 0 | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | 0 | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | 0 | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | 0 | ForeignActivitiesInd |
| More Than5000 K To Org | 0 | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | 0 | GrantsToOrganizationsInd |
| Grants To Individuals | Yes (1) | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | Yes (1) | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 6 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 0 | EmployeeCnt |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 5 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 0 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | Yes (1) | MembersOrStockholdersInd |
| Election Of Board Members | Yes (1) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | 0 | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | 0 | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | 0 | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | 0 | CompensationProcessCEOInd |
| Compensation Process Other | 0 | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AMANDA WALDHAUSER | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 8472091020 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1 PENNSYLVANIA PLAZA 54TH FL | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10119 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (5 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd |
|---|---|---|---|---|---|---|---|
| ERIC VENKER | |||||||
| DIRECTOR | 0.20 | 49.80 | Yes (X) | $0 | $16,220,093 | $5,162,135 | |
| MATTHEW GLINE | |||||||
| DIRECTOR AND SECRETARY | 0.20 | 49.80 | Yes (X) | $0 | $24,803,978 | $185,851,159 | Yes (X) |
| RAKHI KUMAR TO 22025 | |||||||
| DIRECTOR AND TREASURER | 0.20 | 49.80 | Yes (X) | $0 | $4,037,660 | $2,058,756 | Yes (X) |
| DANIEL PATTERSON | |||||||
| DIRECTOR | 0.20 | 49.80 | Yes (X) | $0 | $1,567,059 | $420,313 | |
| LINDSAY ANDROSKI | |||||||
| DIRECTOR, PRESIDENT AND CEO | 4.00 | 46.00 | Yes (X) | $0 | $1,110,342 | $49,318 | Yes (X) |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $0 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $47,739,132 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $193,541,681 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 0 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp
Contractor Name ContractorName
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | WALDHAUSER & ASSOCIATES STRATEGIC ADVISI | BusinessNameLine1Txt |
Contractor Address ContractorAddress
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1208 HULL TERRACE | AddressLine1Txt |
| City | EVANSTON | CityNm |
| State Abbreviation | IL | StateAbbreviationCd |
| ZIP | 60202 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Services | BUSINESS CONSULTING | ServicesDesc |
| Compensation | $159,293 | CompensationAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 1 | CntrctRcvdGreaterThan100KCnt |
| All Other Contributions | $305,032 | AllOtherContributionsAmt |
| Total Contributions | $305,032 | TotalContributionsAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,797 | TotalRevenueColumnAmt |
| Exclusion | $1,797 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $306,829 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $1,797 | ExclusionAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $23,481 | TotalAmt |
| Program Services | $23,481 | ProgramServicesAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $168,725 | TotalAmt |
| Program Services | $122,527 | ProgramServicesAmt |
| Management And General | $42,500 | ManagementAndGeneralAmt |
| Fundraising | $3,698 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,990 | TotalAmt |
| Program Services | $4,990 | ProgramServicesAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $56,920 | TotalAmt |
| Management And General | $56,920 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $411 | TotalAmt |
| Management And General | $411 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $8,438 | TotalAmt |
| Program Services | $8,438 | ProgramServicesAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,934 | TotalAmt |
| Program Services | $3,934 | ProgramServicesAmt |
Other Expenses OtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | PUBLICATION/SUBSCRIPT. | Desc |
| Total | $20,336 | TotalAmt |
| Management And General | $24 | ManagementAndGeneralAmt |
| Fundraising | $20,312 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $287,235 | TotalAmt |
| Program Services | $163,370 | ProgramServicesAmt |
| Management And General | $99,855 | ManagementAndGeneralAmt |
| Fundraising | $24,010 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $337,602 | BOYAmt |
| EOY | $398,756 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $36,224 | BOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| EOY | $9,817 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $250,000 | BOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,525 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $627,351 | BOYAmt |
| EOY | $408,573 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,804 | BOYAmt |
| EOY | $24,000 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $250,000 | BOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $258,804 | BOYAmt |
| EOY | $24,000 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $368,547 | BOYAmt |
| EOY | $384,573 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $368,547 | BOYAmt |
| EOY | $384,573 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $627,351 | BOYAmt |
| EOY | $408,573 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $19,594 | ReconcilationRevenueExpnssAmt |
| Other Changes In Net Assets | -$3,568 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | Yes (1) | AccountantCompileOrReviewInd |
Acct Compile Or Review Basis AcctCompileOrReviewBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| FS Audited | 0 | FSAuditedInd |
| Audit Committee | 0 | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $23,041 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $684,276 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $170,136 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $110,143 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $305,032 | CurrentTaxYearAmt |
| Total | $1,292,628 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $23,041 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $684,276 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $170,136 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $110,143 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $305,032 | CurrentTaxYearAmt |
| Total | $1,292,628 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $167,753 | SubstantialContributorsTotAmt |
| Public Support Total170 | $1,124,875 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus3 Years | $9,516 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $12,957 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $13,750 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,797 | CurrentTaxYearAmt |
| Total | $38,020 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $1,330,648 | TotalSupportAmt |
| Public Support CY170 | 0.84540 | PublicSupportCY170Pct |
| Public Support PY170 | 0.80990 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $0 | TotalBookValueLandBuildingsAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART X, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE ORGANIZATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE-LIKELY-THAN-NOT BE SUSTAINED UPON EXAMINATION BY TAXING AUTHORITIES. MANAGEMENT HAS DETERMINED THAT THE ORGANIZATION HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION. THE ORGANIZATION IS NO LONGER SUBJECT TO AUDITS BY THE APPLICABLE TAXING JURISDICTIONS FOR PERIODS PRIOR TO 2022. CURRENTLY, THERE ARE NO AUDITS IN PROGRESS. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Type | FELLOWSHIPS | GrantTypeTxt |
| Recipient | 2 | RecipientCnt |
| Cash Grant | $23,481 | CashGrantAmt |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 2: | THE ORGANIZATION MONITORED THE USE OF GRANT/FELLOWSHIP FUNDING AND PARTICIPATION THROUGH HAVING EACH GRANT RECIPIENT: 1. PARTICIPATE IN AN INITIAL ONBOARDING MEETING WITH RSV; 2. PARTICIPATE IN AN INFORMATIONAL INTERVIEW WITH RSV THAT WILL BE LEVERAGED TO CREATED A HIGHLIGHT PIECE ON THE FELLOWSHIP WITHIN RSV'S COMMUNICATIONS; 3. PRESENT ON THEIR EXPERIENCE ON BEHALF OF RSV IN NEW YORK CITY IN JULY OF 2025; AND 4. PARTICIPATE IN A FOLLOW UP INTERVIEW WITH RSV. |
| PART III, LINE 1 | DURING FISCAL YEAR 2025, RSV AWARDED FELLOWSHIPS TO TWO INDIVIDUALS TO SUPPORT TRAVEL, LIVING AND OTHER EXPENSES INCURRED WHILE PROVIDING EIGHT WEEKS OF VOLUNTEER SERVICE AT A COMMUNITY PHARMACY CHAIN IN RWANDA. |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | Yes (1) | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (5 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MATTHEW GLINE | ||||||||||||||
| DIRECTOR AND SECRETARY | $0 | $725,000 | $0 | $4,293,750 | $0 | $19,785,228 | $0 | $185,812,067 | $0 | $39,092 | $0 | $210,655,137 | $0 | $0 |
| ERIC VENKER | ||||||||||||||
| DIRECTOR | $0 | $570,000 | $0 | $5,598,750 | $0 | $10,051,343 | $0 | $5,136,303 | $0 | $25,832 | $0 | $21,382,228 | $0 | $0 |
| RAKHI KUMAR TO 22025 | ||||||||||||||
| DIRECTOR AND TREASURER | $0 | $383,438 | $0 | $1,025,789 | $0 | $2,628,433 | $0 | $2,058,756 | $0 | $0 | $0 | $6,096,416 | $0 | $317,650 |
| DANIEL PATTERSON | ||||||||||||||
| DIRECTOR | $0 | $290,857 | $0 | $589,014 | $0 | $687,188 | $0 | $410,061 | $0 | $10,252 | $0 | $1,987,372 | $0 | $184,832 |
| LINDSAY ANDROSKI | ||||||||||||||
| DIRECTOR, PRESIDENT AND CEO | $0 | $312,113 | $0 | $515,653 | $0 | $282,576 | $0 | $25,766 | $0 | $23,552 | $0 | $1,159,660 | $0 | $162,134 |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 3: | NO OFFICER IS COMPENSATED BY THE ORGANIZATION. |
| PART I, LINES 4B-C | WHILE NO OFFICER IS COMPENSATED BY THE FILING ENTITY, OFFICERS HAVE BEEN COMPENSATED FOR THEIR WORK FOR A RELATED ENTITY THAT IS CONSIDERED A BROTHER/SISTER TO THE FILING ENTITY. THE RELATED ENTITY HAS BOTH A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN AND EQUITY BASED COMPENSATION ARRANGEMENT FOR ITS EMPLOYEES, AS HAS BEEN DISCLOSED IN PART II. |
Schedule L IRS990ScheduleL
Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ROIVANT SCIENCES LTD | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Relationship With Org | CREATOR | RelationshipWithOrgTxt |
| Loan Purpose | TO ENABLE RSV TO FUND A LOAN TO AN UNRELATED ENTITY TO SUPPORT ITS PROGRAM | LoanPurposeTxt |
| Loan To Organization | Yes (X) | LoanToOrganizationInd |
| Original Principal | $250,000 | OriginalPrincipalAmt |
| Default | 0 | DefaultInd |
| Board Or Committee Approval | Yes (1) | BoardOrCommitteeApprovalInd |
| Written Agreement | Yes (1) | WrittenAgreementInd |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (8 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 2 | EACH OF THE OFFICERS AND DIRECTORS ARE EMPLOYED BY ROIVANT SCIENCES INC., A WHOLLY CONTROLLED ENTITY OF ROIVANT SCIENCES LTD., ROIVANT SOCIAL VENTURES, INC.'S (THE ORGANIZATION") SOLE MEMBER. |
| FORM 990, PART VI, SECTION A, LINE 6 | ROIVANT SOCIAL VENTURES, INC. HAS A SOLE MEMBER: ROIVANT SCIENCES LTD. |
| FORM 990, PART VI, SECTION A, LINE 7A | AS THE SOLE MEMBER, ROIVANT SCIENCES LTD. HAS THE RIGHT TO: (I) APPROVE THE ELECTION OF DIRECTORS; (II) APPROVE THE NUMBER OF DIRECTORS COMPRISING THE BOARD OF DIRECTORS; (III) REMOVE DIRECTORS WITH OR WITHOUT CAUSE; (IV) APPROVE ANY AMENDMENT TO THE CERTIFICATE OF INCORPORATION OR BYLAWS OF THE CORPORATION ADOPTED BY THE BOARD OF DIRECTORS; (V) APPROVE THE MERGER, SALE OF ALL OR SUBSTANTIALLY ALL OF THE ASSETS, DOMESTICATION, CONVERSION OR DISSOLUTION OF THE CORPORATION, IN EACH CASE AS ADOPTED BY THE BOARD OF DIRECTORS; AND (VI) VOTE FOR SUCH OTHER MATTERS AS MAY BE PROVIDED IN THESE BYLAWS OR THE PROVISIONS OF THE DELAWARE GENERAL CORPORATION LAW. |
| FORM 990, PART VI, SECTION A, LINE 8B | GIVEN THE SIZE OF THE ORGANIZATION'S BOARD OF DIRECTORS, THERE ARE NO FORMAL COMMITTEES. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 IS REVIEWED AND APPROVED BY THE ORGANIZATION'S PRESIDENT AND CEO PRIOR TO FILING. THE BOARD OF DIRECTORS ARE PROVIDED A COPY OF THE 990 PRIOR TO FILING. |
| FORM 990, PART VI, SECTION B, LINE 15 | THE ORGANIZATION HAS NO EMPLOYEES. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION'S FINANCIAL STATEMENTS AND FORM 990 ARE AVAILABLE UPON REQUEST. |
| FORM 990, PART XI, LINE 9: | LOSS ON UNCOLLECTIBLE AMOUNTS -3,568. |
Schedule R IRS990ScheduleR
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (57 entries)
| Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | CountryForeignAddress/CountryCd | Foreign PostalForeignAddress/ForeignPostalCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile Foreign CountryLegalDomicileForeignCountryCd | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Entity TypeEntityTypeTxt | Controlled OrganizationControlledOrganizationInd | Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Legal Domicile StateLegalDomicileStateCd | Province Or StateForeignAddress/ProvinceOrStateNm | Direct Controlling NADirectControllingNACd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AFFIVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981565911 | SCIENTIFIC R&D | SZ | HEMAVANT SCIENCES GMBH | C | 0 | |||||||
| AFFIVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | 981565694 | HOLDING COMPANY | UK | AFFIVANT SCIENCES LTD | C | 0 | |||||||
| AFFIVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONG | UK | SWIH 0DB | 981565414 | HOLDING COMPANY | UK | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ALYVANT LTD | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | 981494184 | HOLDING COMPANY | UK | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ARUVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | SCIENTIFIC R&D | SZ | HEMAVANT SCIENCES GMBH | C | 0 | ||||||||
| ARUVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | 981490198 | SCIENTIFIC R&D | UK | ROIVANT SCIENCES LTD | C | 0 | |||||||
| CLARIVANT INC | ||||||||||||||||
| 333237676 | SCIENTIFIC R&D | ROIVANT SCIENCES LTD | C | 0 | 1 PENNSYLVANIA PLAZA 54TH FLOOR | NEW YORK | NY | 10119 | NY | |||||||
| COVANT THERAPEUTICS OPERATING INC | ||||||||||||||||
| 922630605 | SCIENTIFIC R&D | ROIVANT SCIENCES LTD | C | 0 | 1111B S GOVERNORS AVE | DOVER | DE | 19904 | DE | |||||||
| GENEVANT SCIENCES BIOVENTURES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | SCIENTIFIC R&D | SZ | GENEVANT SCIENCES GMBH | C | 0 | ||||||||
| GENEVANT SCIENCES CORPORATION | ||||||||||||||||
| 887 GRAND NORTHERN WAY | VANCOUVER | CA | V6C 3L6 | 981486273 | SCIENTIFIC R&D | CA | GENEVANT SCIENCES HOLDINGS LIMITED | C | 0 | BRITISH COLUMBIA | ||||||
| GENEVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981468560 | SCIENTIFIC R&D | SZ | GENEVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| GENEVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | 981466897 | HOLDING COMPANY | UK | GENEVANT SCIENCES LTD | C | 0 | |||||||
| GENEVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | 371927500 | SCIENTIFIC R&D | UK | ROIVANT SCIENCES LTD | C | 0 | |||||||
| GENEVANT SCIENCES INC | ||||||||||||||||
| 824617869 | MANAGING OFFICES | GENEVANT SCIENCES HOLDINGS LIMITED | C | 0 | 245 MAIN ST 2ND FL | CAMBRIDGE | MA | 02142 | MA | |||||||
| HAYSTACK HEALTH HOLDINGS COMPANY | ||||||||||||||||
| 920427479 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 1 PENNSYLVANIA PLAZA 54TH FLOOR | NEW YORK | NY | 10119 | NY | |||||||
| HAYSTACK HEALTH COMPANY | ||||||||||||||||
| 920401356 | BIOTECHNOLOGY R&D | HAYSTACK HEALTH HOLDINGS COMPANY | C | 0 | 1 PENNSYLVANIA PLAZA 54TH FLOOR | NEW YORK | NY | 10119 | NY | |||||||
| HEKAHEART HOLDINGS INC | ||||||||||||||||
| 932552859 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 1 PENNSYLVANIA PLAZA 54TH FLOOR | NEW YORK | NY | 10119 | NY | |||||||
| HEKAHEART INC | ||||||||||||||||
| 932585341 | SCIENTIFIC R&D | HEKAHEART HOLDINGS INC | C | 0 | 1 PENNSYLVANIA PLAZA 54TH FLOOR | NEW YORK | NY | 10119 | NY | |||||||
| HEMAVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | SCIENTIFIC R&D | SZ | HEMAVANT SCIENCES HOLDINGS LIMITED | C | 0 | ||||||||
| HEMAVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | 981578379 | HOLDING COMPANY | UK | HEMAVANT SCIENCES LTD | C | 0 | |||||||
| HEMAVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | 981577750 | HOLDING COMPANY | UK | ROIVANT SCIENCES LTD | C | 0 | |||||||
| IMMUNOVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981470927 | SCIENTIFIC R&D | SZ | IMMUNOVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| IMMUNOVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | 981468959 | HOLDING COMPANY | UK | IMMUNOVANT SCIENCES LTD | C | 0 | |||||||
| IMMUNOVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | 981494848 | HOLDING COMPANY | UK | IMMUNOVANT INC | C | 0 | |||||||
| IMMUNOVANT TREASURY INC | ||||||||||||||||
| 882574422 | HOLDING COMPANY | IMMUNOVANT INC | C | 0 | 1000 PARK FORTY PLAZA STE 210 | DURHAM | NC | 27713 | NC | |||||||
| IMMUNOVANT INC (FKA HEALTH SCIENCES ACQUISITIONS CORPORATION) | ||||||||||||||||
| 832771572 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 1000 PARK FORTY PLAZA STE 210 | DURHAM | NC | 27713 | NC | |||||||
| IMVT CORPORATION (FKA IMMUNOVANT INC ) | ||||||||||||||||
| 831251299 | SCIENTIFIC R&D | IMMUNOVANT SCIENCES HOLDINGS LIMITED | C | 0 | 1000 PARK FORTY PLAZA STE 210 | DURHAM | NC | 27713 | NC | |||||||
| IZANA BIOSCIENCE LIMITED | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | HOLDING COMPANY | UK | KINEVANT LTD | C | 0 | ||||||||
| KINEVANT LTD | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | 981495584 | HOLDING COMPANY | UK | ROIVANT SCIENCES LTD | C | 0 | |||||||
| KINEVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981527962 | SCIENTIFIC R&D | SZ | KINEVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| KINEVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | 981527842 | HOLDING COMPANY | UK | KINEVANT SCIENCES LTD | C | 0 | |||||||
| KINEVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | 981494851 | HOLDING COMPANY | UK | KINEVANT LTD | C | 0 | |||||||
| KINEVANT SCIENCES INC | ||||||||||||||||
| 833172270 | SCIENTIFIC R&D | KINEVANT SCIENCES HOLDINGS LIMITED | C | 0 | 1 PENNSYLVANIA PLAZA 54TH FLOOR | NEW YORK | NY | 10119 | NY | |||||||
| LYSOVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981527959 | SCIENTIFIC R&D | SZ | HEMAVANT SCIENCES GMBH | C | 0 | |||||||
| LYSOVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | 981494841 | HOLDING COMPANY | UK | ROIVANT SCIENCES LTD | C | 0 | |||||||
| METAVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | 981463971 | HOLDING COMPANY | UK | ROIVANT SCIENCES LTD | C | 0 | |||||||
| PHARMAVANT 10 INC | ||||||||||||||||
| 874143208 | SCIENTIFIC R&D | ROIVANT SCIENCES INC | C | 0 | 1 PENNSYLVANIA PLAZA 54TH FLOOR | NEW YORK | NY | 10119 | NY | |||||||
| PHARMAVANT 9 LTD | ||||||||||||||||
| C/O CONYERS CORPORATE SERVICES LIMI | HAMILTON | BD | HM11 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | ||||||||
| PRIMAVANT LTD | ||||||||||||||||
| C/O CONYERS CORPORATE SERVICES LIMI | HAMILTON | BD | HM11 | 981527381 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | |||||||
| PRIOVANT HOLDINGS INC | ||||||||||||||||
| 871233821 | BIOTECHNOLOGY R&D | ROIVANT SCIENCES LTD | C | 0 | 1007 SLATER ROAD SUITE 250 | DURHAM | NC | 27703 | NC | |||||||
| PRIOVANT THERAPEUTICS INC | ||||||||||||||||
| 871508551 | BIOTECHNOLOGY R&D | PRIOVANT HOLDINGS INC | C | 0 | 1007 SLATER ROAD SUITE 250 | DURHAM | NC | 27703 | NC | |||||||
| PULMOVANT INC | ||||||||||||||||
| 923322345 | SCIENTIFIC R&D | ROIVANT SCIENCES LTD | C | 0 | 303 WYMAN ST SUITE 300 | WALTHAM | MA | 02451 | MA | |||||||
| PULMOVANT SCIENCES INC | ||||||||||||||||
| 331607074 | SCIENTIFIC R&D | PULMOVANT INC | C | 0 | 303 WYMAN ST SUITE 300 | WALTHAM | MA | 02451 | MA | |||||||
| RESPIVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | 981463960 | HOLDING COMPANY | UK | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ROIVANT DISCOVERY INC | ||||||||||||||||
| 862031998 | SCIENTIFIC R&D | ROIVANT SCIENCES INC | C | 0 | 1 PENNSYLVANIA PLAZA 54TH FLOOR | NEW YORK | NY | 10119 | NY | |||||||
| ROIVANT MS 2 LTD | ||||||||||||||||
| C/O CONYERS CORPORATE SERVICES LIMI | HAMILTON | BD | HM11 | HOLDING COMPANY | BD | ROIVANT SCIENCES LTD | C | 0 | ||||||||
| ROIVANT SCIENCES GMBH | ||||||||||||||||
| VIADUKTSTRASSE 8 | BASEL | SZ | 4051 | 981506527 | SCIENTIFIC R&D | SZ | ROIVANT SCIENCES HOLDINGS LIMITED | C | 0 | |||||||
| ROIVANT SCIENCES HOLDINGS LIMITED | ||||||||||||||||
| 7TH FL 50 BROADWAY | LONDON | UK | SWIH 0DB | 981468948 | HOLDING COMPANY | UK | ROIVANT SCIENCES LTD | C | 0 | |||||||
| ROIVANT SCIENCES IRELAND LIMITED | ||||||||||||||||
| ROCKTWIST HOUSE BLOCK 1 WESTERN BU | SHANNON | EI | V14 FW97 | 981530399 | SCIENTIFIC R&D | EI | ROIVANT SCIENCES HOLDINGS LIMITED | C | 0 | CLARE | ||||||
| ROIVANT SCIENCES LTD | ||||||||||||||||
| 50 BROADWAY 7TH FLOOR | LONDON | UK | SWIH 0DB | 981173944 | HOLDING COMPANY | UK | C | 0 | N/A | |||||||
| ROIVANT SCIENCES INC | ||||||||||||||||
| 465630757 | SCIENTIFIC R&D | ROIVANT SCIENCES HOLDINGS LIMITED | C | 0 | 1 PENNSYLVANIA PLAZA 54TH FLOOR | NEW YORK | NY | 10119 | NY | |||||||
| ROIVANT TREASURY HOLDINGS INC | ||||||||||||||||
| 824789074 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 1 PENNSYLVANIA PLAZA 54TH FLOOR | NEW YORK | NY | 10119 | NY | |||||||
| ROIVANT TREASURY INC | ||||||||||||||||
| 824794439 | HOLDING COMPANY | ROIVANT TREASURY HOLDINGS INC | C | 0 | 1 PENNSYLVANIA PLAZA 54TH FLOOR | NEW YORK | NY | 10119 | NY | |||||||
| SAVANT BIO INC | ||||||||||||||||
| 332462162 | SCIENTIFIC R&D | ROIVANT SCIENCES LTD | C | 0 | 1 PENNSYLVANIA PLAZA 54TH FLOOR | NEW YORK | NY | 10119 | NY | |||||||
| SILICON TX HOLDINGS HK LIMITED | ||||||||||||||||
| UNIT 402 4TH FLOOR FAIRMONT HOUSE | ADMIRALITY | CH | HOLDING COMPANY | CH | ROIVANT MS 2 LTD | C | 0 | HONG KONG | ||||||||
| ZEST DERMATOLOGY HOLDINGS INC | ||||||||||||||||
| 881717991 | HOLDING COMPANY | ROIVANT SCIENCES LTD | C | 0 | 1111B S GOVERNORS AVE STE 81554 | DOVER | DE | 19904 | DE | |||||||
| ZEST DERMATOLOGY INC | ||||||||||||||||
| 881739718 | ADMINISTRATIVE SERVICES | ZEST DERMATOLOGY HOLDINGS INC | C | 0 | 1111B S GOVERNORS AVE STE 81554 | DOVER | DE | 19904 | DE | |||||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | 0 | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | 0 | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | Yes (1) | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | 0 | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | 0 | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | 0 | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (1) | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (1) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | 0 | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | 0 | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp
Other Organization Name OtherOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ROIVANT SCIENCES LTD | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transaction Type | E | TransactionTypeTxt |
| Involved | $250,000 | InvolvedAmt |
| Method Of Amount Determination | FMV | MethodOfAmountDeterminationTxt |